ClinicalTrials.govpublic full text
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
elranatamab, myeloma, multiple myeloma, relapsed multiple myeloma, refractory multiple myeloma, pf-06863135, bcma, bispecific, bispecific antibody, bcma-cd3 bispecific, magnetismm-8, neoplasms, plasma cell
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 888793
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.